2,4,6-trihydroxybenzaldehyde and Colonic Neoplasms

2,4,6-trihydroxybenzaldehyde has been researched along with Colonic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choy, YY; Forester, SC; Oteiza, PI; Waterhouse, AL	1

Other Studies

1 other study(ies) available for 2,4,6-trihydroxybenzaldehyde and Colonic Neoplasms

Article	Year
The anthocyanin metabolites gallic acid, 3-O-methylgallic acid, and 2,4,6-trihydroxybenzaldehyde decrease human colon cancer cell viability by regulating pro-oncogenic signals. Molecular carcinogenesis, 2014, Volume: 53, Issue:6 Topics: Anthocyanins; Apoptosis; Benzaldehydes; Caco-2 Cells; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Colonic Neoplasms; Dose-Response Relationship, Drug; Gallic Acid; Humans; NF-kappa B; Organic Cation Transporter 1; Signal Transduction; STAT1 Transcription Factor; Transcription Factor AP-1	2014

Article

Year

The anthocyanin metabolites gallic acid, 3-O-methylgallic acid, and 2,4,6-trihydroxybenzaldehyde decrease human colon cancer cell viability by regulating pro-oncogenic signals.

Molecular carcinogenesis, 2014, Volume: 53, Issue:6

Topics: Anthocyanins; Apoptosis; Benzaldehydes; Caco-2 Cells; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Colonic Neoplasms; Dose-Response Relationship, Drug; Gallic Acid; Humans; NF-kappa B; Organic Cation Transporter 1; Signal Transduction; STAT1 Transcription Factor; Transcription Factor AP-1

2014